CJC-1295 (no DAC) 10 mg, glass vial, crimp seal, flip-top cap, California Standard Peptides label

Hormones

CJC-1295 (no DAC)

"CJC-1295 (no DAC)", also sold as modified GRF (1-29), refers to a tetrasubstituted analog of growth hormone-releasing hormone (1-29) without the albumin-binding drug affinity complex that defines CJC-1295 proper.

10 mgCS-CJC-10$110.00
Choose a size and add to cart →
Container
Glass vial, crimp seal, flip-top cap
Storage
-20 °C, desiccated
Paperwork
Lot certificate (HPLC + mass spec) shown before you pay

Lot certificates

You’ll see American Peptides on the lab’s copy. They’re our supplier.

  • 10 mg, lot CJC10-0803: 99.76% purity (RP-HPLC), 10.38 mg measured, identity confirmed by mass spec. Issued 2026-08-28 by Bioviridian Inc.. Verify certificate COA7601

Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.

What researchers study it for

  • Structural analog of GHRH(1-29)
  • Doping-control detection in seized material

How it is thought to work

As a GHRH(1-29) analog, it is expected to act on the GHRH receptor of pituitary somatotrophs, but this is inferred from related compounds rather than measured directly. The published CJC-1295 human data (Teichman 2006) concern the DAC version, whose albumin binding extends half-life; those results do not transfer to this form.

Where the research stands

No published human studies. A 2026 peer-reviewed review found no peer-reviewed human studies of CJC-1295 without DAC, placing it in its lowest evidence tier.

Sources

  1. Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.. Endocrinology.
  2. Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, Ruchała M (2026). The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.. Front Endocrinol (Lausanne).
  3. Gajda PM, Holm NB, Hoej LJ, Rasmussen BS, Dalsgaard PW, Reitzel LA, Linnet K (2019). Glycine-modified growth hormone secretagogues identified in seized doping material.. Drug Test Anal.
  4. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.. J Clin Endocrinol Metab.

Read more

For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.

California Standard Peptides

Your cart

0 items · free shipping over $200.00

Your cart is empty.

Buy 2 of a vial and save 10%, 3 and save 15%. Research sets are 15% off, and shipping is free over $200.00.

First order

20% off your first order.

Join the list for first word on new lots, restocks and member pricing. Your code arrives by email and applies by itself at checkout.

One code per email, for your first order. By signing up you agree to get emails from us. Unsubscribe anytime.

For laboratory research use only. 21+.